HAC
IBB icon

Harbor Advisory Corp’s iShares Biotechnology ETF IBB Stock Holding History

Harbor Advisory Corp’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,761
Closed -$1.5M – 83
2025
Q1 		$1.5M Sell
11,761
-55
-0.5% -$7.46K 0.5% 49
2024
Q4 		$1.56M Sell
11,816
-588
-5% -$82.7K 0.51% 48
2024
Q3 		$1.81M Sell
12,404
-385
-3% -$55.7K 0.59% 45
2024
Q2 		$1.76M Buy
12,789
+15
+0.1% +$2K 0.61% 43
2024
Q1 		$1.75M Hold
12,774
– – 0.6% 48
2023
Q4 		$1.74M Hold
12,774
– – 0.62% 48
2023
Q3 		$1.56M Buy
12,774
+130
+1% +$16.5K 0.57% 52
2023
Q2 		$1.61M Sell
12,644
-50
-0.4% -$6.5K 0.57% 50
2023
Q1 		$1.64M Hold
12,694
– – 0.63% 50
2022
Q4 		$1.67M Buy
12,694
+1,213
+11% +$157K 0.68% 45
2022
Q3 		$1.34M Sell
11,481
-635
-5% -$78.9K 0.62% 45
2022
Q2 		$1.43M Sell
12,116
-10,895
-47% -$1.29M 0.62% 45
2022
Q1 		$3M Sell
23,011
-175
-0.8% -$22.8K 1.2% 31
2021
Q4 		$3.54M Sell
23,186
-845
-4% -$131K 1.44% 27
2021
Q3 		$3.88M Sell
24,031
-4,950
-17% -$833K 1.69% 21
2021
Q2 		$4.74M Sell
28,981
-3,585
-11% -$552K 2.14% 16
2021
Q1 		$4.9M Sell
32,566
-115
-0.4% -$18.3K 1.95% 14
2020
Q4 		$4.95M Sell
32,681
-530
-2% -$75.7K 2.62% 10
2020
Q3 		$4.5M Sell
33,211
-200
-0.6% -$27.1K 4.41% 9
2020
Q2 		$4.57M Sell
33,411
-740
-2% -$94.3K 4.63% 8
2020
Q1 		$3.68M Sell
34,151
-380
-1% -$43.8K 3.95% 9
2019
Q4 		$4.16M Sell
34,531
-625
-2% -$69.7K 3.46% 13
2019
Q3 		$3.5M Buy
35,156
+180
+0.5% +$18.8K 3.05% 16
2019
Q2 		$3.82M Sell
34,976
-320
-0.9% -$34K 3.37% 12
2019
Q1 		$3.95M Buy
35,296
+1,295
+4% +$142K 3.53% 11
2018
Q4 		$3.28M Buy
34,001
+10
+0% +$1.06K 3.24% 10
2018
Q3 		$4.14M Sell
33,991
-50
-0.1% -$5.89K 3.59% 8
2018
Q2 		$3.74M Buy
34,041
+330
+1% +$35.3K 3.36% 11
2018
Q1 		$3.6M Buy
33,711
+28,665
+568% +$3.18M 3.3% 10
2017
Q4 		$539K Buy
+5,046
New +$539K 0.52% 34

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Harbor Advisory Corp's IBB Position: Q2 2025 in Review

Harbor Advisory Corp sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 11,761 shares — an estimated $1.5M sold.

Harbor Advisory Corp first reported a position in IBB in Q4 2017 and held it in 30 quarters. The position peaked at $4.95M in Q4 2020. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Harbor Advisory Corp reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Harbor Advisory Corp sold 11,761 iShares Biotechnology ETF shares in Q2 2025, an estimated $1.5M.
  • Harbor Advisory Corp first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 30 quarters.
  • Harbor Advisory Corp's iShares Biotechnology ETF position peaked at $4.95M in Q4 2020.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Harbor Advisory Corp's 13F filing for Q2 2025, filed 12 Aug 2025.